Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 May 3;28(36):49820–49832. doi: 10.1007/s11356-021-13873-y

Does improvement in the environmental sustainability rating help to reduce the COVID-19 cases? Controlling financial development, price level and carbon damages

Muhammad Khalid Anser 1, Bushra Usman 2, Shabir Hyder 3, Abdelmohsen A Nassani 4, Sameh E Askar 5, Khalid Zaman 6,, Muhammad Moinuddin Qazi Abro 4
PMCID: PMC8089134  PMID: 33939085

Abstract

The study’s objective is to evaluate the impact of environmental sustainability rating, financial development, changes in the price level and carbon damages on the new COVID-19 cases in a cross-sectional panel of 17 countries. The study developed two broad models to analyse the relationship between the stated factors at the current level and forecast level. The results show that improvement in the environmental sustainability rating and financial efficiency reduces the COVID-19 cases, while continued economic growth and changes in price level likely to exacerbate the COVID-19 cases across countries. The forecast results suggest the U-shaped relationship between COVID-19 cases and carbon damages controlling financial development, price level and environmental sustainability rating. The variance decomposition analysis shows that carbon damages, environmental sustainability rating and price level changes will largely influence COVID-19 cases over the next year. The soundness of economic and ecological regulated policies would be helpful to contain coronavirus cases globally.

Keywords: Environmental sustainability rating; Carbon damages; COVID-19 pandemic; Financial development, price level; Robust least squares regression

Introduction

The COVID-19 pandemic brings many new challenges and opportunities for economies to correct their economic, environmental and healthcare policies to minimize global healthcare losses. The data for a recent rise in coronavirus infected cases in 17 countries helps to assess the emergence of a second possible wave of infectious disease at a massive scale. The history of infectious diseases is as old as human civilization. Human progress is associated with many of its sufferings. Some of the most challenging and prominent pathogens are presented in Table 1 for ready reference.

Table 1.

Prominent epidemics, outbreaks and pandemics

Pathogen Year Cases/mortality Geographical location References
Influenza (Spanish flu) 1918–1920 100 million deaths out of 500 million cases China to worldwide Saunders-Hastings and Krewski (2016)
Influenza (Asian flu) 1957–1958 2 million deaths China to worldwide
HIV/AIDS 1960–to date 32 million deaths out of 75 million cases Africa to worldwide WHO (2018)
Cholera 1961–to date 29,000 deaths out of 5 million per year South Asia to worldwide WHO (2019)
Influenza (Hong Kong flu) 1968–1969 2 million deaths China to worldwide SinoBiological (2020)
SARS 2002–2003 800 deaths out from 8000 China to 37 countries Chesak (2020)
Influenza (Swine flu) 2009–2010 6 million deaths Mexico to worldwide Bloom and Cadarette (2019)
Ebola 2014–2016 11,325 deaths out from 28,600 West Africa CDCP (2017)
Zika 2015–to date No confirms deaths Brazil and America Partlow (2016)
Dengue 2016 38,000 deaths out of 100 million Worldwide Institute for Health Metrics and Evaluation (2019)
Coronavirus (COVID-19) 2019–2020 26,495 deaths out of 571,678 cases in four months China to worldwide WHO (2020)

The rise in the COVID-19 pandemic alarmed the globalized world to re-focused on the earlier suggested policies to contain infectious diseases. Simultaneously, it has highly needed to assess the leading causes of the deadly contagious diseases again spread out from the boundary. The main focal point of the earlier suggested policies, especially to control COVID-19, was to maintain social distancing, using a preventive mask, and handwashing which was considered the critical strategy to contain coronavirus cases (Wang et al. 2020; Lima-Costa et al. 2020). The number of scholarly writing in support of the suggested economic policies is evident. The conclusive, critical remarks of the earlier findings are as follows, i.e. social distancing helpful to minimize the risk of communicable diseases, including COVID-19 as its spread through close contact, person-to-person transmitted through sneezing, cough, and flu, and lack of necessary handwashing facilities (Wimalawansa 2020). There will be a high need to make our cities more planned to diffuse population per square km of land area. Hence, infectious diseases may be less likely to get infused through close living. The greater need to increase healthcare expenditures in national healthcare bills is desirable to confront epidemic diseases (Schwarz 2021; The New York Times 2020). The marginalized population should need quick healthcare and economic reforms, as infectious diseases, including COVID-19, more likely to affect the poor community, which can cause the spread of contagious diseases to other people. The relief package should be announced for poor people not limited to cash, while to give knowledge about the way of spread infectious diseases from one to another, and what precautions are needed to escape out from it. The government needs to offer some home-based jobs to their poor people, such as giving sewing machines to the poorer women and affiliated with some SMEs that help to stay at their homes and do their work to get some income from it (Anser et al. 2020a).

Daily wage employees, small-sized shop keepers, barbers’ shops and unemployed people suffered from infectious diseases, including COVID-19. The complete city lockdown for 15 to 20 days to prevent epidemic diseases can mainly hit these peoples. They earned a minimum income that insufficient to convert into household savings and unable to utilize lockdown days to meet their families (Sinclair et al. 2020). The government should have to take responsibilities for these families, engage them in their houses by providing direct cash or providing foodstuff at home, or introduce some online work, supporting their families in unprecedented time (Kansiime et al. 2021). The government should give a bailout package of a large sum of money to the financial and business enterprises by providing low interest or zero interest base loans to the industries to keep running their production (Bartik et al. 2020). Insurance companies increase interest premium due to impulsive situation; thus, this sector also bailout either through an allocated fund to prevent epidemic diseases or through any other policies so that economic activities could be stable (Banthin et al. 2020).

The service sector reforms also suggested in the earlier studies to sustain the tourism business during the COVID-19 pandemic, i.e. the people engaged with the tourism sector, transportation, small- and medium-sized enterprises and the construction sector primarily influenced by the epidemic diseases. The rural segment is mainly dependent on international tourism; hence, due to transmitted infectious diseases, inbound tourism substantially declines, which ultimately affect their livelihood (Gaffney and Eeckels 2020). The multifaceted challenges could come simultaneously; thus, the government should not wait for any natural disaster while keeping planning a good day for unwanted bad days (Hadjidemetriou et al. 2020). Table 2 shows the current literature review on infectious diseases across countries.

Table 2.

Current literature on different communicable diseases (including COVID-19) and healthcare expenditures

Authors Country Communicable diseases Causes/symptoms Consequences Prevention Medication
Fukuda et al. (2020) Japan Hepatitis C virus (HCV) Liver failure Healthcare expenditures increases in age groups. The need for economical and effective drug therapies would be beneficial for HCV patients. Oral and injectables are available for HCV-infected people.
Ward et al. (2020) US HIV management HIV is a sexually transmitted disease, while it further spread with infected blood and breastfeeding. It damages the immune system that affects the quality of life of the patient. The HIV patients could bear not only the cost of the therapy while it has associated with some other toxicities, including cardiovascular disease, kidney issues and osteoporosis. The life expectancy can increase with the associated cost of the therapy. There is no such cure rate of HIV patients while symptomatic treatment is given to the patients to increase life expectancy.
Njau et al. (2019) Romania Measles and rubella Rashes, fever, lymph nodes, flu, headache, red eyes, etc. The cost of measles and rubella outbreaks was US$9.9 million, among which measles and rubella per cost of patients were around the US$439 and US$132, respectively. Further, the result indicates that about 36% of households could not afford this high viral cost, thus have to borrow it from other sources. Routine vaccination would be helpful to reduce the economic burden. MMR vaccine primarily used for this viral disease.
Pedrazzoli et al. (2019) A general survey across countries Tuberculosis TB is more prone due to poverty, lack of knowledge, income and financial issues. The economic consequences are apparent, which includes reduced labour supply, low labour productivity, less income and household resilience. TB DOTS programme, patient-centred TB services and free medicines given to the needy people would help cure this disease. The four-drug therapy primarily used in the first phase then decrease up to three or two medicines. It is around 6 to 8 months of medication treatment that is curable.
Albuquerque et al. (2019) Brazil Zika virus Children are affected mainly by the Zika virus, leading to cognitive impairment, epilepsy, visual problems and arthrogryposis. The low priority areas, marginalized population and inability to afford healthcare prices affected mainly by the Zika virus. Frequent healthcare visits and regular follow-up with the physicians would positively prevent the Zika virus. There is no specific vaccine and medicine; thus, it mainly treats it through symptomatic medication.
Kum et al. (2019) Sierra Leone Ebola virus Unexplained haemorrhaging is the main symptom. The disease negatively affects the country’s budget due to the affected countries’ food and mining business disclosure. Clinical care and the patient’s immune response would mainly prevent it from this disease. The FDA approves the Ebola vaccine rVSV-ZEBOV.
Bai et al. (2020) China COVID-19 Viral pneumonia resulted in the outbreak of coronavirus. Fever, cough, body pain and respiratory problems are common symptoms. Social distancing suggests prevention. There is no such vaccine or medicine for this viral infection. Self-isolation and quarantine hospitals/places recommended.
Grasselli et al. (2020) Italy COVID-19 The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lead to COVID-19. Treatment that does not respond to atypical pneumonia may lead to COVID-19. Intensive care units build up and allocated for COVID-19 patients. Set up local procedures for the triage of patients with respiratory issues.
Adalja et al. (2020) US COVID-19 SARS-CoV-2 lead to COVID-19. Healthcare workers are mainly in danger to expose directly to COVID-19 patients. The need for a proper healthcare system is required to confront this disease. Diagnostic testing, local hospitals and clinics need to move quickly forward to tackle the disease.
Murthy et al. (2020) General survey COVID-19 The SARS, the Middle East respiratory syndrome and different severe influenza, including A(H7N9) and A(H1N1), are the integral components of this infectious disease. Older patients (median age ≈ 60 years) are affected mainly by this virus, while milder illnesses found in children. Increase urine intensity, lung-protective ventilation and reduced lung inflation are recommended for possibly minimizing the severity of this disease. An early antibiotic for symptomatic treatment suggested following some other healthcare guidelines to confront this virus; however, there is no such specific vaccine/medicine until yet launched to reduced mortalities. Precaution is the only medicine.

The sustainability agenda compromised in the wake of the COVID-19 pandemic. The sustainable development projects and green innovation programs are halts due to the exacerbation of COVID-19 cases. Environmental knowledge is highly needed to promote green behaviour, which possibly is effective through advancement in ethical leadership (Ahmad et al. 2021). Individual green values also in line with the promotion of ethical leadership to support green human resource development (Islam et al. 2020a). Technology advancement played a vital role to conceive a green and clean environmental agenda, which is imperative for long-run sustained economic growth (Batool et al. 2019). Corporate social responsibility and green environmental behaviours help achieve the sustainability agenda (Islam et al. 2019). The resulting impact of the COVID-19 pandemic was limited to the deteriorating healthcare sustainability agenda. Simultaneously, the food retail business and customer’s mistreatment also affected, which need pro-active resource agenda to treat customers more efficiently (Ahmed et al. 2021). Communicable diseases, including COVID-19, increase healthcare expenditures leading to global depression (Anser et al. 2020b). Information technologies help disseminate the susceptibility rate of coronavirus cases and update the latest information to take preventive measures worldwide (Islam et al. 2020b).

Based on the earlier literature, the study could get a research gap between environmental sustainability and COVID-19 cases from different perspectives. First, the previous studies mainly used carbon emissions as an environmental proxy in the relationship of COVID-19 pandemic (see Han et al. 2021; Balsalobre-Lorente et al. 2020; Le Quéré et al. 2020), while this study used environmental sustainability rating index, which gives new insights of the relationship to control COVID-19 cases. Second, the study used money supply as financial development proxy in the COVID-19 modelling framework to assess the possible impact of financial openness leading to COVID-19 cases. The few studies worked on the relationship between financial development and COVID-19 cases (see Anser et al. 2021; Humpe and McMillan 2020; Silaswara et al. 2020). However, this study also used the financial indicator in new predicted COVID-19 cases, giving more insights into the relationship at inter-temporal settings. Finally, the study used carbon damages and its square term in the forecasted COVID-19 cases modelling framework, which does not previously address the non-linearity in the later stages of exacerbating COVID-19 cases. This unique contribution of the study opens many new avenues in the scholarly writings, enabling policymakers to devise sustainable environmental policies worldwide.

The study comprehensively discussed the possible vulnerabilities of the COVID-19 pandemic. It focused on the re-emergence of coronavirus cases as a possible second wave in many parts of the globalized world that need to be contained through solicited efforts. The study found some new and vital factors requiring careful examination to control them with sound global economic policies. After the first wave of COVID-19, the government used easy economic policies to support their financial and business affairs. The high socialization and commercialization process among the economic agents would probably be the more significant cause of the re-emergence of newly infected coronavirus cases across countries. Based on this assumption, the study evaluated many essential factors as research objectives of the study, i.e.

  • i)

    To critically examine the government policies in terms of socialization and commercialization that likely to a new rise in coronavirus infected cases.

  • ii)

    To analyse the cost of carbon emissions that would be the possible cause of re-emergence of the high level of newly infected coronavirus cases across countries, and

  • iii)

    To assure improvement in the environmental sustainability ratings that probably begins to decline coronavirus cases at a massive scale.

These objectives would be evaluated through panel cross-sectional statistical techniques and would help reach some conclusive findings. The government should have to make all policies in good time. If any epidemic plague arises in the future, the government efficiently managed their resources and fought the epidemic diseases.

Data source and methodological framework

The study used the following critical predictors of the second wave of possible COVID-19 pandemic that can view in the new infected cases (denoted by NEW) in 17 countries, i.e. carbon damages (denoted by CDAM) as % of GNI, money supply (denoted by M2) as % of GDP, GDP per capita (denoted by GDPPC) in constant 2010 US$, inflation-consumer price index (denoted by CPI) in annual % and CPIA policy and institutions for environmental sustainability rating (denoted by ESR) (1 = low to 6 = high) index value. The stated factors’ data on the current period were taken from Worldometer (2020) and World Bank (2020). Figure 1 shows the rise in the newly infected cases in 17 countries for ready reference.

Fig. 1.

Fig. 1

Rise in new infected COVID-19 cases. Source: Worldometer (2020, dated 19th October 2020

The given variables used to represent different economic substitutions to observe more critical scenario of the possible second wave of COVID-19 pandemic across countries, i.e.

  • i)

    New infected COVID-19 cases (NEW): The rise in the new infected COVID-19 cases, used as a ‘response’ variable. It served as a possible factor for identifying the second wave of COVID-19 cases across countries. The increase in new cases found in 17 countries collected from the Worldometer (2020) on 19th October 2020. The study simulated more infected cases based on the given data, and it has been used as a central stimulus to direct more critical factors to the healthcare agenda.

  • ii)

    Environmental sustainability agenda: The study used two different environmental factors that would probably be a cause an increase in newly infected cases, including carbon damages and environmental regulations. It assumed that an increase in carbon emissions damages the healthcare sustainability agenda. Hence, a person with infectious diseases in a healthcare constraint environment has more incidence to get infected (Anser et al. 2020c). The second factor is environmental regulation, which assessed through a rating index. The more significant environmental regulations would enable to minimize the incidence of infectious diseases and helpful to sustained healthcare activities.

  • iii)

    Socialization: The more significant change in money supply and continued economic growth leads to an increase in more economic activity that probably is a cause of more social interaction among the economic agents, which may lead to getting infected from COVID-19 cases. The monetary transactions in healthcare infrastructure provision would enable us to get back off from infectious diseases, including COVID-19.

  • iv)

    Commercialization: The commercial activities exacerbated after the first wave of the COVID-19 pandemic. The commodity prices increase due to the high demand for the goods that obstructed during the COVID-19 epidemic. This situation would cause the second wave of COVID-19 pandemic, which needs to be lookup with sound economic policies.

Based on the stated discussion, the study made the following equation to assess the possible cause of the second wave of COVID-19 pandemic across countries, i.e.

1nNEW=α0+α11n(E+α21n(M+α31nGDPPC17,2020+α41n(C+ε17,20201nNEW1nESR<0,1nNEW1nMS.>0,1nNEW1nGDPPC>0,1nNEW1nCPI>0 1

Where ln shows natural logarithm, NEW shows newly infected cases, ESR shows environmental sustainability rating, MS shows money supply, GDPPC shows GDP per capita, CPI shows inflation, ‘ln’ shows natural logarithm and ε shows error term.

Equation (1) shows that improvement in the environmental sustainability rating would reduce newly infected coronavirus cases. In contrast, economic policies and commercial activities would cause a recent rise in COVID-19 cases across countries. The study further simulated newly infected patients based on Eq. (1) and estimated Eq. (2), i.e.

1nNEWF=α0+α11n(C+α2ln(S+α3ln(E+α4ln(M+α5ln(G+α6ln(C+ε17,2020lnNEWFlnCDAM<0,lnNEWFlnSQCDAM>0,lnNEWFlnESR<0,lnNEWFlnMS.>0,lnNEWFlnGDPPC>0,lnNEWFlnCPI>0 2

Where NEWF shows forecasted newly infected cases, CDAM shows carbon damages and SQCDAM shows a square of CDAM.

Equation (2) shows that carbon damages exhibit a curvy linear relationship with new forecasted coronavirus cases with a negative and positive sign at the initial and final environmental degradation level. Figure 2 shows the research framework of the study.

Fig. 2.

Fig. 2

Research framework. Source: Self-extract

Figure 2 shows that the second wave of possible spread of COVID-19 cases is probably the cause of the high level of commercial activities and economic socialization due to expansionary monetary policies, which increases the money supply and credit creation across countries. The increased need for healthcare spending would support environmental sustainability rating while decreasing infectious diseases on a massive scale. The following hypotheses proposed to test the possible cause of an increase in COVID-19 cases across countries, i.e.

  • H1: It is a likelihood that an increase in commercialization activities and socialization leads to a rise in newly infected coronavirus cases.

The study hypothesizes that increasing commercialization activities through the stock market’s upsurge begins to rise new COVID-19 cases. Increasing close contacts between economic agents in buying and selling process leads to more epidemic challenges, which need to be contained by managing standardized operating procedures.

  • H2: The easy economic policies likely to bind close connection between economic agents and suppliers that increases corporate payoffs at the expense of healthcare damages.

The second hypothesize more focused on the expansionary fiscal and monetary policy, where government spending increases on public goods and interest rate declines, leading to more investment in the economy that exacerbates the susceptibility of increasing new COVID-19 cases across countries, and

  • H3: Environmental sustainability rating would likely improve through increasing healthcare spending across countries.

Finally, the third hypothesis is more focused on maintaining the environmental sustainability rating that improves the quality of life and healthcare infrastructure, leading to reducing the risk of increasing COVID-19 cases globally.

These hypotheses have empirically tested by robust least square regression apparatus and variance decomposition analysis. The economic relationship checked by ordinary least square regression; however, this procedure has certain limitations that cannot minimize possible outliers from the stimulus variable and its regressand. The greater need for handling potential outliers in cross-sectional models, where the country size has variated as per their factor endowment, required more robust regression to minimize structural adjustment shocks across the cross-sections. The robust least square regression gives more sound inferences to absorb complete outliers across cross-sections and provides sound parameter estimates. The VAR economic modelling offers facilitation to assess innovation shocks in the stimulus variable about the regressand over a while. Both the empirical modelling techniques enable one to mark some conclusive findings.

Results and discussion

Table 3 shows the descriptive statistics of the candidate variables. The minimum increase in newly infected cases is 2, and the maximum points reached 9138 with a mean value of 1356. The carbon damages, changes in the price level and environmental sustainability rating have a mean value of 2.607% of GNI, 3.174% and 3.117 index point, respectively. The per capita income has a minimum amount of US$1116.358, a maximum value of US$57,071.17 and a mean value of US$13,371.53. The money supply has reached an average amount of 77.672% across countries.

Table 3.

Descriptive statistics

Methods NEW CDAM CPI ESR GDPPC MS
Mean 1356 2.607 3.174 3.117 13,371.53 77.672
Maximum 9138 5.618 10.578 4 57,071.17 197.017
Minimum 2 0.613 0.382 3 1116.358 17.831
Std. Dev. 2472.148 1.722 3.044 0.281 17,593.98 48.125
Skewness 2.177 0.686 1.150 2.249 1.478 0.990
Kurtosis 6.913 2.108 3.237 6.925 3.763 3.352

Note: NEW shows new infected cases, CDAM shows carbon damages, CPI shows inflation, ESR shows environmental sustainability rating, GDPPC shows per capita GDP and MS shows money supply

Table 4 shows the estimates of robust least square regression and found that environmental sustainability rating and economic policies regarding healthcare money supply on infrastructure development mainly decrease new coronavirus infected cases with elasticity estimates of − 16.703% p < 0.000 and − 3.09% p<0.000, respectively. The result implies that environmental regulations supporting an increase in healthcare expenditures would help minimize new coronavirus cases (Rupani et al. 2020; Allam and Jones 2020). Further needed global economic actions to mitigate climate changes through an increase in R&D expenditures (Eissa 2020), healthcare logistics supply (Govindan et al. 2020), testing and labs facility (Pulia et al. 2020), knowledge spillover (Anser et al. 2020b) and implementation of healthcare guidelines associated SOPs at a significant level (Smith et al. 2020).

Table 4.

Robust least squares regression estimates for Eq. (1)

Dependent variable: ln(NEW)
Variable Coefficient Std. Error z-Statistic Prob.
C 29.004 5.460 5.311 0.000
ln(ESR) − 16.703 3.487 − 4.789 0.000
ln(GDPPC) 0.888 0.244 3.626 0.000
ln(CPI) 0.814 0.280 2.899 0.003
ln(MS) − 3.095 0.448 − 6.895 0.000
Robust statistics
R2 0.526 Adjusted R2 0.369
Rw2 0.939 Adjust Rw2 0.939
AIC 44.014 SIC 51.055
Rn2 85.478 Prob(Rn2) 0.000

Note: NEW shows new infected cases, CPI shows inflation, ESR shows environmental sustainability rating, GDPPC shows per capita GDP and MS offers money supply

The results further show that commercialization and socialization are the two main predictors that mainly cause a rise in the newly infected coronavirus cases. Socialization has a greater magnitude, i.e. 0.888%, p < 0.000 in terms of commercialization, i.e. 0.814%, p < 0.003, that exacerbate a second possible incidence wave of coronavirus across selected countries. The high socialization and commercialization activities among economic agents would probably overlook the COVID-19 guidelines that lead to the newly infected coronavirus cases (Silveira et al. 2020; Kutscher and Greene 2020). The greater need for maintaining social distancing (Wilder-Smith and Freedman 2020), wearing face masks (Wu et al. 2020), avoid physical contacts (Razai et al. 2020) and use hand washing facilities (Cavanagh and Wambier 2020) are essential from prevention of new rise in COVID-19 cases across countries. Table 5 shows the diagnostic testing estimates to comprehend the given results.

Table 5.

Diagnostic test estimates for Eq. (1)

Variables Variance inflation factors (VIF) Other tests
ln(ESR) 1.135

JB test: 0.468

Prob. Value: (0.791)

ln(GDPPC) 1.313

Autocorrelation LM test: 0.565

Prob. Value: (0.585)

ln(CPI) 1.171

Heteroskedasticity test: 1.205

Prob. Value: (0.358)

ln(MS) 1.120

Ramsey RESET test: 1.242

Prob. Value: 0.239

Note: CPI shows inflation, ESR shows environmental sustainability rating, GDPPC shows per capita GDP and MS offers money supply

Table 5 confirms that the cross-section variables have no potential multicollinearity issue, as the value of VIF is less than the threshold value of 10. The other statistics confirmed that the given variables have no normality, autocorrelation, heteroskedasticity and model specification. Figure 3 shows the model stability at their 5% level of significance.

Fig. 3.

Fig. 3

Model stability tests for Eq. (1). Source: Author’s estimate

As illustrated in Fig. 3, the model stability estimates confirm that the given statistics of CUSUM and square of CUSUM fall in the 5% critical region; thus, the given Eq. (1) of its parameters is statistically stable at provided point of time. Table 6 shows the robust least square regression for Eq. (2) and found a curvy relationship between carbon damages and new forecasted coronavirus cases. Initially, an increase in carbon damages does not respond to the latest possible wave of coronavirus. However, high carbon damages lead to increased healthcare damages that react to the new wave of coronavirus disease later. Thus, it exhibits the U-shaped relationship between them. The result implies that environmental pollution is the cause of healthcare damages that leads to the patient’s low immune system that quickly affects any infectious diseases (Kang et al. 2020a, b, Xiang et al. 2020, Lima et al. 2020). The COVID-19 is a deadly contagious disease that infected more quickly ill patients and where the patients’ immune system is critically compromised, thus its cause of spreading infectious diseases (Ogen 2020; Abdi 2020).

Table 6.

Robust least square regression estimates for Eq. (2)

Dependent variable: ln(NEWF)
Variable Coefficient Std. Error z-Statistic Prob.
C 29.002 1.032 28.089 0.000
ln(CDAM) − 0.585 0.181 − 3.215 0.001
ln(SQCDAM) 0.298 0.135 2.199 0.027
ln(ESR) − 12.623 0.646 − 19.528 0.000
ln(CPI) 0.612 0.052 11.778 0.000
ln(MS) − 2.352 0.117 − 20.096 0.000
Robust statistics
R2 0.880 Adjusted R2 0.826
Rw2 0.994 Adjust Rw2 0.994
AIC 20.294 SIC 28.889
Rn2 1511.871 Prob(Rn2) 0.000

Note: NEWF shows new forecast infected cases, CDAM shows carbon damages, SQDAM shows a square of CDAM, CPI shows inflation, ESR shows environmental sustainability rating, GDPPC shows per capita GDP and MS shows money supply

The other results show that environmental sustainability regulations would be supportive enough to minimize coronavirus cases’ possible re-occurrence. Its possibly be minimized by improving the health hygiene of the patients (Ung 2020), increasing nutritional diets and supplements (BourBour et al. 2020), proper healthcare counselling (Brownstone et al. 2020), (Silva et al. 2020) and mitigating air pollution (Saha and Chouhan 2020). The commercialization activities exacerbate new infectious cases; however, its effect can be minimized through an increase in ease in economic policies to support the healthcare agenda (Shereen et al. 2020). Thus, the greater need for social protection through safety nets programme and employment generated policies would embark on long-term sustained healthcare policies that are pivotal for sustainable development across countries (Akseer et al. 2020). Table 7 shows the diagnostic testing estimates for Eq. (2) for ready reference.

Table 7.

Diagnostic test estimates for Eq. (2)

Variables VIF Other tests
ln(CDAM) 7.158

JB test: 0.941

Prob. Value: (0.624)

ln(SQCDAM) 9.143

Autocorrelation LM test: 1.646

Prob. Value: (0.245)

ln(ESR) 1.202

Heteroskedasticity test: 0.581

Prob. Value: (0.713)

ln(CPI) 1.235
ln(MS) 2.347

Note: CDAM shows carbon damages, SQDAM shows a square of CDAM, CPI shows inflation, ESR shows environmental sustainability rating, GDPPC shows per capita GDP and MS shows money supply

The results confirmed the basic diagnostic statistics that exhibit the ‘no common error’ related to the usual stochastic characteristics, including the normality issue, serial correlation and heteroskedasticity. VIF value also comprehends the free from the multicollinearity issues among the regressors, which remains inside the threshold value of 10. The closeness of value near the threshold value of 10 for CDAM and its square term is evident due to the quadratic relationship between the CDAM and NEWF; however, it does not necessarily imply the collinear relationship among the stated variables. This illustration can be view in Fig. 4 for ready reference. The CUSUM and CUSUM square terms confirmed the model’s stability for Eq. (2), as it falls inside the 5% level of confidence.

Fig. 4.

Fig. 4

Model stability tests for Eq. (2). Source: Author’s estimate

Table 8 shows that carbon damages and commercialization have a greater magnitude to influence NEW cases and NEWF cases, respectively, over the next 1-year time period. The share of environmental sustainability rating is far more significant in the NEW instances relative to the NEWF cases. Socialization and economic easiness also would likely influence NEW cases and NEWF cases over a while. The share of the money supply is more outstanding in NEW cases relative to NEWF cases during the coming months. These statistics would help assess the current and forecasted trend of a new possible wave of COVID-19 cases across countries.

Table 8.

Variance decomposition estimates

Variance decomposition of ▲ln(NEW)
Months SE. ▲ln(NEW) ▲ln(CDAM) ▲ln(CPI) ▲ln(ESR) ▲ln(GDPPC) ▲ln(MS)
January 2021 2.654876 99.44022 0.434700 0.025601 0.002212 0.083785 0.013486
February 2021 2.659966 99.07438 0.689012 0.043968 0.033965 0.099237 0.059434
March 2021 2.660194 99.06047 0.696863 0.046784 0.036024 0.099241 0.060616
April 2021 2.660198 99.06023 0.696866 0.046926 0.036051 0.099290 0.060632
May 2021 2.660198 99.06022 0.696872 0.046927 0.036052 0.099294 0.060639
June 2021 2.660198 99.06021 0.696873 0.046927 0.036052 0.099294 0.060639
July 2021 2.660198 99.06021 0.696873 0.046927 0.036052 0.099294 0.060639
August 2021 2.660198 99.06021 0.696873 0.046927 0.036052 0.099294 0.060639
September 2021 2.660198 99.06021 0.696873 0.046927 0.036052 0.099294 0.060639
Variance decomposition of ▲ln(NEWF)
Months SE. ▲ln(NEWF) ▲ln(CDAM) ▲ln(CPI) ▲ln(ESR) ▲ln(GDPPC) ▲ln(MS)
February 2021 2.259445 99.56116 0.145534 0.167805 0.101744 0.023752 2.25E-08
March 2021 2.259966 99.54227 0.158234 0.172984 0.101747 0.024764 2.26E-08
April 2021 2.259984 99.54074 0.158641 0.174017 0.101820 0.024786 2.26E-08
May 2021 2.259985 99.54066 0.158651 0.174058 0.101841 0.024786 2.26E-08
June 2021 2.259985 99.54066 0.158654 0.174059 0.101842 0.024786 2.26E-08
July 2021 2.259985 99.54066 0.158654 0.174059 0.101842 0.024786 2.26E-08
August 2021 2.259985 99.54066 0.158654 0.174059 0.101842 0.024786 2.26E-08
September 2021 2.259985 99.54066 0.158654 0.174059 0.101842 0.024786 2.26E-08

Note: ▲ shows the first difference, ln shows natural logarithm, CDAM shows carbon damages, SQDAM shows a square of CDAM, CPI shows inflation, ESR shows environmental sustainability rating, GDPPC shows per capita GDP and MS shows money supply

Conclusions

The study aims to analyse the possible determinants of a new rise in COVID-19 cases in a panel of 17 global economies. These countries mainly selected due to an increase in COVID-19 new infected cases. The study found three main vital factors that could cause coronavirus diseases, i.e. close socialization among economic agents, more splendid commercialization activities and environmental deregulations. These factors mainly accessed by the continued economic growth, changes in the price level and high carbon damages. The other two main possible factors help minimize healthcare losses, i.e. sound economic policies and improved sustainability rating. These factors have accessed through an increase in money supply and environmental sustainability rating scale.

The number of microorganisms spread in the air and could infect people. For instance, vector-borne and zoonotic diseases, like Ebola, malaria, rabies, etc.; water-and food-borne diseases, like typhoid, dysentery, cholera, etc.; and endemic fungal diseases, like skin problems, dermatitis, etc., are exposed to climate change. Besides some direct measures in the current period, the government should have to plan some long-term policies related to the production of carbon-free goods, strict environmental regulations, the imposition of carbon taxes on dirty industries, healthcare-associated environmental certifications and advancement in cleaner production technologies. All these strategies would help minimize epidemic diseases by mitigating high carbon and fossil fuel combustion at a global scale.

Policy implications

The study suggested the following five policy implications that would be helpful to control the second possible wave of coronavirus cases, i.e.

  • i)

    To monitor ‘socialization and commercialization’ activities among economic agents during business-related transactions and emphasize the need to implement entire COVID-19 guidelines in the buying and selling process. Thus, the need to maintain social distancing is pivotal to minimize newly infected cases.

  • ii)

    To regulate environmental policies that would reduce high carbon costs to achieve the healthcare sustainability agenda. The rise in carbon emissions led to an increase in patient’s illness and low immune system, which quickly infected from coronavirus disease. The need to improve environmental sustainability ratings is imperative to escape from coronavirus disease by achieving a healthy immune system, using nutritional diets and supplements, and civilizing sanitation facilities.

  • iii)

    The soundness of economic and healthcare policies deemed desirable to improve healthcare logistics infrastructure. A rise in R&D spending in launching the coronavirus vaccine, preventing coronavirus policies, involved community stakeholders and local investors, avoid massive gatherings and increase self-awareness and protocol, largely supporting the healthcare sustainability agenda.

  • iv)

    Financial development is essential to begin economic activities while maintaining commodity price level reduces economic sufferings from the vulnerable segment of the society. Hence, it is essential to improve stock market efficiency through strict compliance of COVID-19 cases, while government should have to subsidize food products by lowering their prices to support the lower-income group in the wake of the COVID-19 pandemic, and

  • v)

    Human development formation is vital to understand all the three possible indices of human progress related to a healthy life, knowledge diffusion and decent living standards. A healthy and informative person may be able to compliance all suggested measures to contain coronavirus cases. Hence, it is essential to move forward to achieve healthcare sustainability across countries.

Thus, the need to re-focus on earlier preventive policies and re-address new possible wave of coronavirus cases to contain infectious diseases required at nipping in the bud.

Acknowledgements

Researchers Supporting Project number (RSP-2021/87), King Saud University, Riyadh, Saudi Arabia.

Author contribution

MKA: Conceptualization, Methodology, Writing-Reviewing and Editing. BU: Software, Formal Analysis. SH: Methodology Formal Analysis AAN: Supervision, Resources, Software. SEA: Formal Analysis, Resources. KZ. Software, Formal Analysis, Resources. MMQA: Resources, visualization, Formal Analysis.

Funding

Researchers Supporting Project number (RSP-2021/87), King Saud University, Riyadh, Saudi Arabia

Data Availability

The data is freely available at Worldometer (2020) at https://www.worldometers.info/coronavirus/ and World Development Indicators published by World Bank (2020) at https://databank.worldbank.org/source/world-development-indicators.

Declarations

Ethical approval

Not applicable.

Consent to participate

All authors are equally participated in the study.

Consent for publication

All authors allow the publication of the paper.

Competing interests

The authors declare that they have no conflict of interest.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Muhammad Khalid Anser, Email: mkhalidrao@xauat.edu.cn, Email: khalidsnnu@yahoo.com.

Abdelmohsen A. Nassani, Email: Nassani@ksu.edu.sa

Sameh E. Askar, Email: saskar@ksu.edu.sa

Khalid Zaman, Email: khalid_zaman786@yahoo.com.

Muhammad Moinuddin Qazi Abro, Email: mqazi@ksu.edu.sa.

References

  1. Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: actions and problems. Infect Control Hosp Epidemiol. 2020;41(6):754–755. doi: 10.1017/ice.2020.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adalja AA, Toner E, Inglesby TV. Priorities for the US health community responding to COVID-19. Jama. 2020;323(14):1343–1344. doi: 10.1001/jama.2020.3413. [DOI] [PubMed] [Google Scholar]
  3. Ahmad S, Islam T, Sadiq M, Kaleem A (2021) Promoting green behavior through ethical leadership: a model of green human resource management and environmental knowledge. Leadersh Org Dev J ahead-of-print. 10.1108/LODJ-01-2020-0024
  4. Ahmed I, Islam T, Ahmad S, Kaleem A (2021) A COVID-19 contextual study of customers’ mistreatment and counterproductive work behavior at coffee cafés. Br Food J ahead-of-print. 10.1108/BFJ-07-2020-0664
  5. Akseer N, Kandru G, Keats EC, Bhutta ZA. COVID-19 pandemic and mitigation strategies: implications for maternal and child health and nutrition. Am J Clin Nutr. 2020;112(2):251–256. doi: 10.1093/ajcn/nqaa171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Albuquerque MS, Lyra TM, Melo AP, Valongueiro SA, Araújo TV, Pimentel C, ..., Penn-Kekana L (2019) Access to healthcare for children with Congenital Zika Syndrome in Brazil: perspectives of mothers and health professionals. Health Pol Plann 34(7):499-507 [DOI] [PMC free article] [PubMed]
  7. Allam Z, Jones DS (2020) On the coronavirus (COVID-19) outbreak and the smart city network: universal data sharing standards coupled with artificial intelligence (AI) to benefit urban health monitoring and management. In Healthcare (Vol. 8, No. 1, p. 46). Multidisciplinary Digital Publishing Institute [DOI] [PMC free article] [PubMed]
  8. Anser MK, Yousaf Z, Khan MA, Nassani AA, Alotaibi SM, Abro MMQ, ..., Zaman K (2020a) Does communicable diseases (including COVID-19) may increase global poverty risk? A cloud on the horizon. Environ Res 187:109668 [DOI] [PMC free article] [PubMed]
  9. Anser MK, Islam T, Khan MA, Zaman K, Nassani AA, Askar SE, …, Kabbani A (2020b) Identifying the potential causes, consequences, and prevention of communicable diseases (including COVID-19). BioMed Res Int, Article ID 8894006, 10.1155/2020/8894006 [DOI] [PMC free article] [PubMed]
  10. Anser MK, Yousaf Z, Khan MA, Voo XH, Nassani AA, Alotaibi SM, Abro MMQ, Zaman K. The impacts of COVID-19 measures on global environment and fertility rate: double coincidence. Air Qual Atmos Health. 2020;13(9):1083–1092. doi: 10.1007/s11869-020-00865-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Anser MK, Khan MA, Zaman K, Nassani AA, Askar SE, Abro MMQ, Kabbani A. Financial development during COVID-19 pandemic: the role of coronavirus testing and functional labs. Finan Innov. 2021;7(1):1–13. doi: 10.1186/s40854-021-00226-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020;323(14):1406–1407. doi: 10.1001/jama.2020.2565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Balsalobre-Lorente D, Driha OM, Bekun FV, Sinha A, Adedoyin FF. Consequences of COVID-19 on the social isolation of the Chinese economy: accounting for the role of reduction in carbon emissions. Air Qual Atmos Health. 2020;13(12):1439–1451. [Google Scholar]
  14. Banthin J, Simpson M, Buettgens M, Blumberg LJ, Wang R. Changes in health insurance coverage due to the COVID-19 recession: preliminary estimates using microsimulation. Washington, DC: Urban Institute; 2020. [Google Scholar]
  15. Bartik AW, Bertrand M, Cullen Z, Glaeser EL, Luca M, Stanton C. The impact of COVID-19 on small business outcomes and expectations. Proc Natl Acad Sci. 2020;117(30):17656–17666. doi: 10.1073/pnas.2006991117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Batool R, Sharif A, Islam T, Zaman K, Shoukry AM, Sharkawy MA, Gani S, Aamir A, Hishan SS. Green is clean: the role of ICT in resource management. Environ Sci Pollut Res. 2019;26(24):25341–25358. doi: 10.1007/s11356-019-05748-0. [DOI] [PubMed] [Google Scholar]
  17. Bloom DE,  Cadarette D (2019) Infectious disease threats in the twenty-first century: strengthening the global response. Front Immunol 10:549. 10.3389/fimmu.2019.00549 [DOI] [PMC free article] [PubMed]
  18. BourBour F, Mirzaei Dahka S, Gholamalizadeh M, Akbari ME, Shadnoush M, Haghighi M, Taghvaye-Masoumi H, Ashoori N, Doaei S (2020) Nutrients in prevention, treatment, and management of viral infections; special focus on coronavirus. Arch Physiol Biochem:1–10. 10.1080/13813455.2020.1791188 [DOI] [PubMed]
  19. Brownstone ND, Thibodeaux QG, Reddy VD, Myers BA, Chan SY, Bhutani T, Liao W. Novel coronavirus disease (COVID-19) and biologic therapy in psoriasis: infection risk and patient counseling in uncertain times. Dermatol Ther. 2020;10(3):339–349. doi: 10.1007/s13555-020-00377-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Cavanagh G, Wambier CG. Rational hand hygiene during the coronavirus 2019 (COVID-19) pandemic. J Am Acad Dermatol. 2020;82(6):e211. doi: 10.1016/j.jaad.2020.03.090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Centers for Disease Control and Prevention (2017) 2014-2016: Ebola outbreak in West Africa. Available online at: https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html (accessed 12th February, 2019)
  22. Chesak J (2020) Can we learn anything from SARS to fight COVID-19? Available at: https://www.healthline.com/health-news/has-anything-changed-since-the-2003-sars-outbreak (Accessed on 17th March, 2020)
  23. Eissa N. Pandemic preparedness and public health expenditure. Economies. 2020;8(3):60. doi: 10.3390/economies8030060. [DOI] [Google Scholar]
  24. Fukuda H, Yano Y, Sato D, Ohde S, Noto S, Watanabe R, Takahashi O. Healthcare expenditures for the treatment of patients infected with hepatitis C virus in Japan. PharmacoEconomics. 2020;38:297–306. doi: 10.1007/s40273-019-00861-x. [DOI] [PubMed] [Google Scholar]
  25. Gaffney C, Eeckels B. COVID-19 and tourism risk in the Americas. J Lat Am Geogr. 2020;19(3):308–313. [Google Scholar]
  26. Govindan K, Mina H, Alavi B. A decision support system for demand management in healthcare supply chains considering the epidemic outbreaks: a case study of coronavirus disease 2019 (COVID-19) Transport Res E: Logistics Transport Rev. 2020;138:101967. doi: 10.1016/j.tre.2020.101967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. Jama. 2020;323(16):1545–1546. doi: 10.1001/jama.2020.4031. [DOI] [PubMed] [Google Scholar]
  28. Hadjidemetriou GM, Sasidharan M, Kouyialis G, Parlikad AK. The impact of government measures and human mobility trend on COVID-19 related deaths in the UK. Transport Res Interdiscip Perspect. 2020;6:100167. doi: 10.1016/j.trip.2020.100167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Han P, Cai Q, Oda T, Zeng N, Shan Y, Lin X, Liu D. Assessing the recent impact of COVID-19 on carbon emissions from China using domestic economic data. Sci Total Environ. 2021;750:141688. doi: 10.1016/j.scitotenv.2020.141688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Humpe A, McMillan D. The Covid-19 stock market puzzle and money supply in the US. Econ Bull. 2020;40(4):3104–3110. [Google Scholar]
  31. Institute for Health Metrics and Evaluation (2019) GBD results tool. Available online at: http://ghdx.healthdata.org/gbd-results-tool. (Accessed 12th February, 2019)
  32. Islam T, Ali G, Asad H. Environmental CSR and pro-environmental behaviors to reduce environmental dilapidation. Manag Res Rev. 2019;42(3):332–351. [Google Scholar]
  33. Islam T, Khan MM, Ahmed I, Mahmood K (2020a) Promoting in-role and extra-role green behavior through ethical leadership: mediating role of green HRM and moderating role of individual green values. Int J Manpow. 10.1108/IJM-01-2020-0036 ahead-of-print
  34. Islam T, Mahmood K, Sadiq M, Usman B, Yousaf SU (2020b) Understanding knowledgeable workers’ behavior toward COVID-19 information sharing through WhatsApp in Pakistan. Front Psychol 11. 10.3389/fpsyg.2020.572526 [DOI] [PMC free article] [PubMed]
  35. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry. 2020;7(3):e14. doi: 10.1016/S2215-0366(20)30047-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kang L, Ma S, Chen M, Yang J, Wang Y, Li R, et al. Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: a cross-sectional study. Brain Behav Immun. 2020;87:11–17. doi: 10.1016/j.bbi.2020.03.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kansiime MK, Tambo JA, Mugambi I, Bundi M, Kara A, Owuor C. COVID-19 implications on household income and food security in Kenya and Uganda: findings from a rapid assessment. World Dev. 2021;137:105199. doi: 10.1016/j.worlddev.2020.105199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kum FV, Olayiwola S, Aloysius NM (2019) The impact of Ebola virus disease on government expenditure in Sierra Leone. In Socio-cultural dimensions of emerging infectious diseases in Africa (pp. 75-90). Springer, Cham
  39. Kutscher E, Greene RE (2020) A harm-reduction approach to coronavirus disease 2019 (COVID-19)—safer socializing. In JAMA Health Forum (Vol. 1, No. 6, pp. e200656-e200656). American Medical Association [DOI] [PubMed]
  40. Le Quéré C, Jackson RB, Jones MW, Smith AJ, Abernethy S, Andrew RM, ..., Peters GP (2020) Temporary reduction in daily global CO 2 emissions during the COVID-19 forced confinement. Nat Clim Chang 10(7):647-653
  41. Lima CKT, de Medeiros Carvalho PM, Lima IDAAS, de Oliveira Nunes JVA, Saraiva JS, de Souza RI, ..., Neto MLR (2020) The emotional impact of coronavirus 2019-nCoV (new coronavirus disease). Psychiatry Res 287:112915 [DOI] [PMC free article] [PubMed]
  42. Lima-Costa MF, Mambrini JVDM, Andrade FBD, Peixoto SWV, Macinko J. Social distancing, use of face masks and hand washing among participants in the Brazilian Longitudinal Study of Aging: the ELSI-COVID-19 initiative. Cadernos de Saúde Pública. 2020;36:e00193920. doi: 10.1590/0102-311X00193920. [DOI] [PubMed] [Google Scholar]
  43. Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. Jama. 2020;323(15):1499–1500. doi: 10.1001/jama.2020.3633. [DOI] [PubMed] [Google Scholar]
  44. Njau J, Janta D, Stanescu A, Pallas SS, Pistol A, Khetsuriani N, Reef S, Ciurea D, Butu C, Wallace AS, Zimmerman L. Assessment of economic burden of concurrent measles and rubella outbreaks, Romania, 2011–2012. Emerg Infect Dis. 2019;25(6):1101–1109. doi: 10.3201/eid2506.180339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ogen Y. Assessing nitrogen dioxide (NO2) levels as a contributing factor to the coronavirus (COVID-19) fatality rate. Sci Total Environ. 2020;726:138605. doi: 10.1016/j.scitotenv.2020.138605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Partlow J (2016) As Zika virus spreads, El Salvador asks women not to get pregnant until 2018. Washington Post, 117-20. Available from: https://www.washingtonpost.com/world/the_americas/as-zika-virus-spreads-el-salvador-asks-women-not-to-get-pregnant-until-2018/2016/01/22/1dc2dadcc11f-11e5-98c8-7fab78677d51_story.html. (Accessed on 10th October, 2020)
  47. Pedrazzoli D, Borghi J, Viney K, Houben RMGJ, Lönnroth K. Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks. Int J Tuberculosis Lung Dis. 2019;23(1):5–11. doi: 10.5588/ijtld.18.0318. [DOI] [PubMed] [Google Scholar]
  48. Pulia MS, O’Brien TP, Hou PC, Schuman A, Sambursky R. Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic. Ann Med. 2020;52(5):207–214. doi: 10.1080/07853890.2020.1763449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Razai MS, Doerholt K, Ladhani S, Oakeshott P (2020) Coronavirus disease 2019 (covid-19): a guide for UK GPs. BMJ 368. 10.1136/bmj.m800 [DOI] [PubMed]
  50. Rupani PF, Nilashi M, Abumalloh RA, Asadi S, Samad S, Wang S. Coronavirus pandemic (COVID-19) and its natural environmental impacts. Int J Environ Sci Technol. 2020;17:4655–4666. doi: 10.1007/s13762-020-02910-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Saha J, Chouhan P. Indoor air pollution (IAP) and pre-existing morbidities among under-5 children in India: are risk factors of coronavirus disease (COVID-19)? Environ Pollut. 2020;266:115250. doi: 10.1016/j.envpol.2020.115250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Saunders-Hastings PR, Krewski D. Reviewing the history of pandemic influenza: understanding patterns of emergence and transmission. Pathogens. 2016;5(4):1–19. doi: 10.3390/pathogens5040066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Schwarz C. Freed from insurance: health care sharing ministries and the moralization of health care. Soc Sci Med. 2021;268:113453. doi: 10.1016/j.socscimed.2020.113453. [DOI] [PubMed] [Google Scholar]
  54. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91–98. doi: 10.1016/j.jare.2020.03.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Silaswara D, Gunawan I, Fung TS. Analysis of money circulating in Indonesia during Covid-19 pandemic. Primanomics: Jurnal Ekonomi & Bisnis. 2020;18(3):36–46. [Google Scholar]
  56. Silva RRD, Santos MBD, Santos ADD, Tavares DDS, Santos PLD. Coronavirus disease and basic sanitation: too early to be worried? Rev Soc Bras Med Trop. 2020;53:1–5. doi: 10.1590/0037-8682-0345-2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Silveira MR, Junior NFF, Cocco RG, Felácio RM, Rodrigues LA. Novel coronavirus (Sars-Cov-2): spatial diffusion and another level for the socialization of investments in Brazil. Revista Brasileira de Estudos Urbanos e Regionais. 2020;22:e202024en. [Google Scholar]
  58. Sinclair RR, Allen T, Barber L, Bergman M, Britt T, Butler A, Ford M, Hammer L, Kath L, Probst T, Yuan Z. Occupational health science in the time of COVID-19: now more than ever. Occup Health Sci. 2020;4:1–22. doi: 10.1007/s41542-020-00064-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. SinoBiological (2020) SARS-CoV-2 (COVID-19 virus) research. Beijing, P.R. China. Online available at: https://www.sinobiological.com/ (accessed on 11Novemver, 2020)
  60. Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, Caffery LJ. Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19) J Telemed Telecare. 2020;26(5):309–313. doi: 10.1177/1357633X20916567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. The New York Times (2020) Coronavirus may add billions to the nation’s health care bill. Online available at: https://www.nytimes.com/2020/03/28/health/coronavirus-insurance-premium-increases.html (accessed on 30th May, 2020)
  62. Ung COL. Community pharmacist in public health emergencies: quick to action against the coronavirus 2019-nCoV outbreak. Res Soc Adm Pharm. 2020;16(4):583–586. doi: 10.1016/j.sapharm.2020.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wang Y, Tian H, Zhang L, Zhang M, Guo D, Wu W, ..., Liu B (2020) Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China. BMJ Global Health 5(5):e002794 [DOI] [PMC free article] [PubMed]
  64. Ward T, Sugrue D, Hayward O, McEwan P, Anderson SJ, Lopes S, Punekar Y, Oglesby A. Estimating HIV management and comorbidity costs among aging HIV patients in the United States: a systematic review. J Manag Care Special Pharm. 2020;26(2):104–116. doi: 10.18553/jmcp.2020.26.2.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020;27(2):taaa020. doi: 10.1093/jtm/taaa020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Wimalawansa SJ. Global epidemic of coronavirus—Covid-19: what can we do to minimize risks. Eur J Biomed. 2020;7(3):432–438. [Google Scholar]
  67. World Bank . World development indicators. Washington DC: World Bank; 2020. [Google Scholar]
  68. World Health Organization (2018). Global Health Observatory (GHO) data. Available at: https://www.who.int/gho/hiv/en/ (Accessed on 28th March 2020)
  69. World Health Organization (2019). Cholera. Available online at: https:// www.who.int/news-room/fact-sheets/detail/cholera (accessed 28 March 2020)
  70. Worldometer (2020) COVID-19 pandemic: coronavirus cases. Online available at: https://www.worldometers.info/coronavirus/ (accessed on 19th October, 2020)
  71. Wu HL, Huang J, Zhang CJ, He Z, Ming WK. Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: reflections on public health measures. EClinicalMedicine. 2020;21:100329. doi: 10.1016/j.eclinm.2020.100329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7(3):228–229. doi: 10.1016/S2215-0366(20)30046-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data is freely available at Worldometer (2020) at https://www.worldometers.info/coronavirus/ and World Development Indicators published by World Bank (2020) at https://databank.worldbank.org/source/world-development-indicators.


Articles from Environmental Science and Pollution Research International are provided here courtesy of Nature Publishing Group

RESOURCES